139755-85-4,MFCD00908400
Catalog No.:AA001BLC

139755-85-4 | 5-(2-Ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
95%
1 week  
$112.00   $79.00
- +
2mg
95%
1 week  
$134.00   $94.00
- +
50mg
95%
1 week  
$156.00   $109.00
- +
100mg
95%
1 week  
$234.00   $164.00
- +
250mg
95%
1 week  
$413.00   $289.00
- +
1g
95%
1 week  
$1,551.00   $1,086.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA001BLC
Chemical Name:
5-(2-Ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one
CAS Number:
139755-85-4
Molecular Formula:
C23H32N6O5S
Molecular Weight:
504.6024
MDL Number:
MFCD00908400
SMILES:
CCCc1nn(c2c1nc([nH]c2=O)c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC1)CCO)C
Properties
Properties
 
Form:
Solid  
MP:
>182°C (dec.)  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
872  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
35  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
9  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.8  

Downstream Synthesis Route

[1]Terrett,NicholasK.;Bell,AndrewS.;Brown,David;Ellis,Peter[BioorganicandMedicinalChemistryLetters,1996,vol.6,#15,p.1819-1824]

[1]BioorganicandMedicinalChemistryLetters,1996,vol.6,p.1819-1824

[1]Terrett,NicholasK.;Bell,AndrewS.;Brown,David;Ellis,Peter[BioorganicandMedicinalChemistryLetters,1996,vol.6,#15,p.1819-1824]

[2]Sthalam,VinayKumar;Mahajan,Bhushan;Karra,PurushothamReddy;Singh,AjayK.;Pabbaraja,Srihari[RSCAdvances,2021,vol.12,#1,p.326-330]

[1]Terrett,NicholasK.;Bell,AndrewS.;Brown,David;Ellis,Peter[BioorganicandMedicinalChemistryLetters,1996,vol.6,#15,p.1819-1824]

Literature

Title: Toque HA, et al. Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum. Eur J Pharmacol. 2008 Sep 4;591(1-3):189-95.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:139755-85-4 Molecular Formula|139755-85-4 MDL|139755-85-4 SMILES|139755-85-4 5-(2-Ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one
Catalog No.: AA001BLC
139755-85-4,MFCD00908400
139755-85-4 | 5-(2-Ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one
Pack Size: 1mg
Purity: 95%
1 week
$112.00 $79.00
Pack Size: 2mg
Purity: 95%
1 week
$134.00 $94.00
Pack Size: 50mg
Purity: 95%
1 week
$156.00 $109.00
Pack Size: 100mg
Purity: 95%
1 week
$234.00 $164.00
Pack Size: 250mg
Purity: 95%
1 week
$413.00 $289.00
Pack Size: 1g
Purity: 95%
1 week
$1,551.00 $1,086.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA001BLC
Chemical Name: 5-(2-Ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one
CAS Number: 139755-85-4
Molecular Formula: C23H32N6O5S
Molecular Weight: 504.6024
MDL Number: MFCD00908400
SMILES: CCCc1nn(c2c1nc([nH]c2=O)c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC1)CCO)C
Properties
Form: Solid  
MP: >182°C (dec.)  
Storage: Keep in dry area;2-8℃;  
Complexity: 872  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 35  
Hydrogen Bond Acceptor Count: 9  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 9  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.8  
Downstream Synthesis Route
103-76-4    139756-21-1    139755-85-4 

[1]Terrett,NicholasK.;Bell,AndrewS.;Brown,David;Ellis,Peter[BioorganicandMedicinalChemistryLetters,1996,vol.6,#15,p.1819-1824]

42926-52-3    139755-85-4 

[1]BioorganicandMedicinalChemistryLetters,1996,vol.6,p.1819-1824

139756-02-8    139755-85-4 

[1]Terrett,NicholasK.;Bell,AndrewS.;Brown,David;Ellis,Peter[BioorganicandMedicinalChemistryLetters,1996,vol.6,#15,p.1819-1824]

[2]Sthalam,VinayKumar;Mahajan,Bhushan;Karra,PurushothamReddy;Singh,AjayK.;Pabbaraja,Srihari[RSCAdvances,2021,vol.12,#1,p.326-330]

139756-03-9    139755-85-4 

[1]Terrett,NicholasK.;Bell,AndrewS.;Brown,David;Ellis,Peter[BioorganicandMedicinalChemistryLetters,1996,vol.6,#15,p.1819-1824]

Building Blocks More >
14003-96-4
14003-96-4
7-Hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde
AA001BVV | MFCD12027255
1403766-89-1
1403766-89-1
4-(Piperidin-4-yl)thiomorpholine 1,1-dioxide dihydrochloride
AA001C85 | MFCD22581548
14073-97-3
14073-97-3
(2S,5R)-2-Isopropyl-5-methylcyclohexanone
AA001COI | MFCD00001634
14088-99-4
14088-99-4
1-(4-Chlorophenyl)imidazolidin-2-one
AA001CW8 | MFCD01721093
1457-85-8
1457-85-8
Ethyl oxanilate
AA001D92 | MFCD00009118
146033-02-5
146033-02-5
Dibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-[1-oxo-3-(4-pyridinyl)propyl]hydrazide, hydrochloride (1:1)
AA001DJM | MFCD17215974
146307-51-9
146307-51-9
Methyl trans-4-(N-Boc-amino)cyclohexanecarboxylate
AA001DTG | MFCD17015041
146670-40-8
146670-40-8
Benzoic acid, 4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dioxolan-2-yl]-
AA001E4V | MFCD00864137
14702-32-0
14702-32-0
2,5-Furandione, dihydro-3,3-diphenyl-
AA001EGA | MFCD30834505
14731-40-9
14731-40-9
Pyrrolidine, 1-(3-butyn-1-yl)-
AA001EPH | MFCD18841064
Submit
© 2017 AA BLOCKS, INC. All rights reserved.